Roswell Park Comprehensive Cancer Center
Book chronicles history of National Cancer Act, NCI-designated cancer centers
Retired oncologist Donald L. “Skip” Trump, MD, FACP, has co-written a book detailing the history of the National Cancer Act of 1971 and the development of NCI-designated cancer centers.
Biden relaunches Moonshot with aim to cut cancer deaths by at least 50% in 25 years
President Joe Biden has unfinished business with cancer.
Chronic diseases increasingly common among adult cancer survivors
The number of adult cancer survivors in the United States with comorbid illnesses and multiple chronic conditions has increased considerably since 2002, according to study results published in Cancer.
Daily e-cigarette use boosted odds of cigarette discontinuation in those without a plan to quit
Among smokers who did not have an initial plan to stop smoking, daily e-cigarette use was associated with higher odds of cigarette discontinuation, according to results published in JAMA Network Open.
NCCN updates guidance on COVID-19 prevention for patients with cancer
National Comprehensive Cancer Network has issued updated guidance on COVID-19 vaccination and pre-exposure prophylaxis for patients with cancer.
Addition of gilteritinib to azacitidine may benefit certain patients with FLT-mutated AML
Gilteritinib plus azacitidine conferred significantly higher complete remission rates, but similar OS, vs. azacitidine among patients with newly diagnosed, FLT3-mutated acute myeloid leukemia ineligible for intensive induction chemotherapy.
Roswell Park appoints chair in gynecologic oncology
Emese Zsiros, MD, PhD, has been promoted to lead the department of gynecologic oncology at Roswell Park Comprehensive Cancer Center.
FDA approvals in gastrointestinal cancers spark excitement in field
FDA approvals of immunotherapies are among several exciting developments during the past couple of years in the field of upper gastrointestinal cancers, according to a speaker at Chemotherapy Foundation Symposium.
Roswell Park appoints CAR T-cell pioneer as new deputy director
Renier Brentjens, MD, PhD, has been appointed deputy director and chair of the department of medicine of Roswell Park Comprehensive Cancer Center.
Roswell Park’s opioid-restricting postoperative protocol reduces use safely, substantially
For patients who have undergone surgery as part of their cancer treatment, the need to manage postoperative pain often must be weighed against the need to avoid conversion to chronic opioid use.